je.st
news
Is Exact Sciences Poised For A Monopoly On Colon Cancer Screening?
2015-02-18 11:29:09| Biotech - Topix.net
There will be around 130,000 new cases of colorectal cancer and close to 50,000 deaths due to colorectal cancer in the U.S. in 2015 alone. Cologuard from Exact Sciences is FDA approved and has a screening detection rate of 93% compared to closest competitor at 73%.
Tags: exact
sciences
cancer
screening
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||